Analysis of FDA FY2019 Drug GMP Warning Letters
By Barbara W. Unger
In this report, you’ll see a detailed 11-page summary of the drug GMP warning letters issued in FY2019, as well as a comparison of trends since FY2013.
Download the report
Get Complete Access to the Redica Systems Platform
Please submit your email address and one of our team members will contact you shortly to answer all of your questions and get you started with the new Enforcement Analytics platform.
